Report Categories
View AllRecent Articles
View All
Gossamer Bio GOSS Investors Reminded of June 1 2026 Securities Class Action Deadline
Samir Arora Refutes Claims That SIPs Are Driving Rupee Weakness
Health Care Sector Attracts Investor Focus as Wellness Trends Gain Momentum
Kiplinger Highlights Key Earnings Reports for May 2529 Week
Japan and Philippines Forge Closer Security Ties with IntelligenceSharing Talks
BillionToOne Inc BLLN Q1 2026 Earnings Strong Earnings Surprise Amid Operational Discipline
BEBE Q3 2016 Earnings EPS Plunges 194 Below Estimates as Operating Losses Deepen
FBIO Q4 2025 Earnings Deep EPS Miss Highlights Challenges for PreRevenue Biotech
VTVT Q1 2026 Earnings Massive EPS Beat Driven by OneTime Items Stock Declines
XERS Q1 2026 Earnings EPS Beat Driven by Strong Operational Execution
BHRB Stock Slips 109 as Burke Herbert Financial Tests Key Support Levels
Super League Enterprise Plunges 11 as Bears Take Control Below 463 Resistance
Solid Power Inc Warrant SLDPW Surges 29 as Warrants Catch Up with Underlying Stock
Nuveen Virginia Quality Municipal Income Fund NPV Edges Higher Amid Steady Municipal Bond Demand
April Jobs Report Expected to Show Cooling but Resilient Labor Market
Forum Energy Technologies Reports 8 Revenue Growth in First Quarter
Bitcoin Slips Below 76000 Heads for Weekly Loss as Liquidations and Rate Volatility Weigh
MACOM and IQE Announce LongTerm Supply Agreements Bolstering Semiconductor Supply Chain
External Links
Why Chasing High Returns May Undermine LongTerm Investment Success
TDG Q1 2026 Earnings EPS Surpasses Estimates on Robust Aerospace Demand
MIRA Q3 2025 Earnings NarrowerThanExpected Loss Lifts Shares
TISI Q1 2026 Earnings Widening Losses as Company Navigates Challenging Market Conditions
CNTA Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Advances Pipeline
Deluxe Corporation DLX Q1 2026 Earnings Strong EPS Beat Amidst Operational Focus
SOWG Q3 2025 Earnings Massive EPS Miss Highlights Operational Headwinds
Ferrari RACE Q1 2026 Earnings EPS Slightly Above Estimates Shares Gain 222
IMVT Q1 2026 Earnings EPS Misses Estimates as Clinical Investment Intensifies
Altimmune Q1 2026 Earnings EPS Beats Estimates Amid Continued Pipeline Development